PERSPECTIVE THERAPEUTICS Trademark

Serial Number: 99900238

PERSPECTIVE THERAPEUTICS is a trademark filed by Perspective Therapeutics, Inc. on June 23, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

1

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Perspective Therapeutics, Inc. (8 trademarks)

350 Hills St., Suite 106
Richland, WA 99354

Entity Type: 03

Legal Representation

Attorney of Record

Sandra L Etherton

641 trademarks filed View all →

Correspondence Address

Sandra L Etherton ETHERTON LAW GROUP, LLC

PO Box 13808

Scottsdale, AZ 85267

United States

Trademark Details

Filing Date

June 23, 2026

Registration Date

Not Registered

Goods & Services

Medical and scientific research in the field of cancer treatment and diagnosis; scientific research and development services in the field of radiopharmaceuticals and nuclear medicine; contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific and technological services relating to the development of targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms

Active chemical ingredients for use in the manufacture of anti-cancer drugs; radiopharmaceutical chemical compounds; radiolabeled chemical compounds comprising alpha-emitting radionuclides; bifunctional chelating agents for conjugating radionuclides to targeting molecules; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing

Pharmaceutical products for the treatment of cancer; radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer comprising prostate cancer, breast cancer, pancreatic cancer, colorectal cancer, or neuroendocrine tumors; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology